Skip to content

Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar

Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02175537
Enrollment
64
Registered
2014-06-26
Start date
2014-06-30
Completion date
2014-11-30
Last updated
2014-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioral Lifestyle Change, Diabetes Mellitus, Type II, Hypertension, Overweight and Obesity, Social Change

Keywords

Diabetes Mellitus, Type II, Disease management, Obesity, Social Network, Chronic disease, Prevention and control, Education

Brief summary

The purpose of the study is to pilot-phase test the effectiveness of the microclinic social induction model and its effects on behavioral and metabolic outcomes in different levels of social and familial relationships in Qatar. The investigators novel microclinic model is based on the principle that both healthy and unhealthy behaviors spread through preexisting social networks. A microclinic is a small group of approximately 2-8 friends or family members who are taught to modify their own behaviors as well as the behaviors of those around them, with a particular focus on the four M's: Meals, Movement, Monitoring, and Medication. More than social support groups or peer-to-peer interventions, the microclinic model is unique in its focus on the long-term propagation of healthy behaviors throughout a participant's entire social network. Qatar is uniquely positioned (with its central geographic location in the Gulf region and its leadership in science and education) to spearhead a regional intervention focused on managing and preventing diabetes in the Gulf region.

Detailed description

This pilot study, Microclinic Social Induction Intervention for Diabetes and Obesity Management in Qatar, is a two-arm randomized controlled trial of a 7-week condensed intervention to evaluate the efficacy of the microclinic social induction model on propagating lifestyle changes and in improving glycemic and metabolic control in Doha, Qatar. The microclinic social induction model leverages different levels of social and familial relationships to positively influence behaviors relating to diabetes and other metabolic conditions through small treatment units called 'microclinic groups,' consisting of 2-8 peers and family members of the same social network. The intervention model brings microclinic groups to a larger classroom network (\ 25 people/class) where each class shares access to a culturally salient diabetes educational curriculum and group support to promote health behavior changes such as improvement in diet, exercise, medication adherence, and blood pressure management to then influence better glycemic and metabolic control.

Interventions

BEHAVIORALMicroclinic Social Induction Diabetes and Obesity Program

Microclinics consist of 2-8 individuals from pre-existing social networks (friends, relatives, coworkers, neighbors, etc) that voluntarily participate in ongoing education and medical monitoring from local health care professionals, learning and practicing diabetes management strategies, sharing much-needed medical supplies, and exchanging social support.

Sponsors

Qatar University
CollaboratorOTHER
Qatar Foundation
CollaboratorUNKNOWN
Qatar Diabetes Association
CollaboratorUNKNOWN
Qatar Supreme Council of Health
CollaboratorUNKNOWN
Harvard School of Public Health (HSPH)
CollaboratorOTHER
Microclinic International
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years old * Mentally competent * Body Mass Index of 30 or higher * Body Mass Index of 25 or higher and self-reported pre-diabetes or type II diabetes

Exclusion criteria

* They do not meet the above criteria * They are pregnant * They have significant medical complications that prevent them from making changes to diet or level of physical activity.

Design outcomes

Primary

MeasureTime frameDescription
WeightWeekly measurements between baseline and end of trial after 7 weeksChange in body weight (and BMI)
HbA1cBaseline, end of trial after 7 weeksChange in HbA1c from baseline to end of 7-week pilot phase.
Waist circumferenceBaseline, 4th-week midpoint, 7th-week final

Secondary

MeasureTime frameDescription
Blood PressureBaseline, 4th-week midpoint, 7th-week finalSystolic and diastolic blood pressure changes
Health Profile SurveyBaseline, end of trial after 7 weeks.Change in overall health seeking and health maintenance behaviors.

Other

MeasureTime frameDescription
Social Network RelationshipsBaseline, end of trial after 7 weeks.Changes in degree of interpersonal health support relationships as assess on Social Network Matrix instrument

Countries

Qatar

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026